OXBDF - Oxford BioMedica's (OXBDF) CEO John Dawson on Q4 2018 Results - Earnings Call Transcript
Oxford BioMedica PLC (OXBDF)
Q4 2018 Earnings Conference Call
March 14, 2019 8:00 AM ET
Company Participants
Catherine Isted – Head-Corporate Development and IR
John Dawson – Chief Executive Officer
Stuart Paynter – Chief Financial Officer
Conference Call Participants
Amy Walker – Peel Hunt
Philippa Gardner – Jefferies
Daniel Wilkinson – Edison
Gary Waanders – Bryan Garnier
Julie Simmonds – Panmure Gordon
Brian White – Cantor
Joe Pantginis – H.C. Wainwright
Caroline Palomeque – Maxim Group
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Oxford Biomedica Preliminary Results 2018 Webcast and Conference